|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.999
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.998
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.998
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.998
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.996
|
Worm |
|
|
heart process
|
GO:0003015 |
94 |
0.996
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.996
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.995
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.995
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.994
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.994
|
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.994
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.993
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.993
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.992
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.992
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.992
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.992
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.991
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.990
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.990
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.989
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.989
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.982
|
Worm |
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.980
|
|
|
|
skeletal muscle adaptation
|
GO:0043501 |
16 |
0.977
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.977
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
21 |
0.974
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.973
|
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.969
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
25 |
0.968
|
|
|
|
cell communication involved in cardiac conduction
|
GO:0086065 |
9 |
0.961
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.959
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.958
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.956
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.955
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.954
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.954
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.950
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.948
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.944
|
Worm |
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.940
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.938
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.934
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.933
|
|
|
|
regulation of muscle adaptation
|
GO:0043502 |
31 |
0.932
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.931
|
|
|
|
cardiac conduction
|
GO:0061337 |
17 |
0.929
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.927
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.920
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.919
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.914
|
|
|
|
regulation of atp metabolic process
|
GO:1903578 |
17 |
0.912
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.904
|
|
|
|
regulation of cardiac muscle contraction by calcium ion signaling
|
GO:0010882 |
9 |
0.901
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.901
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.897
|
|
|
|
regulation of atp catabolic process
|
GO:1903289 |
9 |
0.890
|
|
|
|
regulation of cardiac muscle cell contraction
|
GO:0086004 |
11 |
0.877
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.875
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.872
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.865
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.862
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.860
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.850
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.848
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.845
|
|
|
|
transition between fast and slow fiber
|
GO:0014883 |
9 |
0.844
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.835
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.834
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.833
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.833
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.822
|
|
|
|
cardiac muscle cell action potential involved in contraction
|
GO:0086002 |
6 |
0.817
|
|
|
|
regulation of heart rate
|
GO:0002027 |
36 |
0.807
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.806
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.805
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.801
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
23 |
0.799
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.794
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.794
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.791
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.789
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.785
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.785
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.785
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.780
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.774
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.771
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.762
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.759
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.758
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.757
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.745
|
|
|
|
regulation of membrane depolarization
|
GO:0003254 |
11 |
0.745
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.742
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.737
|
|
|
|
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0010880 |
10 |
0.735
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.734
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.733
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.730
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.730
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.720
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.717
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.717
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.714
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.706
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.702
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.702
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.699
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.693
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.693
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.686
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.681
|
|
|
|
regulation of skeletal muscle adaptation
|
GO:0014733 |
12 |
0.678
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.674
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.673
|
|
|
|
cardiac muscle cell action potential
|
GO:0086001 |
11 |
0.666
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.662
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.653
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.652
|
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.648
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.647
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.646
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.644
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.635
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.635
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.627
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.623
|
|
|
|
positive regulation of calcium ion transmembrane transporter activity
|
GO:1901021 |
8 |
0.617
|
|
|
|
regulation of mitochondrial fission
|
GO:0090140 |
3 |
0.615
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.614
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.613
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.608
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.607
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.604
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.603
|
|
|
|
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
GO:0010881 |
7 |
0.603
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.599
|
|
|
|
calcium ion transport from endoplasmic reticulum to cytosol
|
GO:1903514 |
12 |
0.597
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.596
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.594
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.589
|
|
|
|
endoplasmic reticulum to cytosol transport
|
GO:1903513 |
12 |
0.585
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.585
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.581
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.581
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.581
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.580
|
|
|
|
regulation of atrial cardiac muscle cell membrane depolarization
|
GO:0060371 |
5 |
0.579
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.577
|
|
|
|
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
GO:0014808 |
12 |
0.575
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.573
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
31 |
0.564
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.555
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.544
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.543
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.541
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.533
|
|
|
|
his purkinje system cell differentiation
|
GO:0060932 |
2 |
0.526
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.516
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.515
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.508
|
Mouse |
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.507
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.507
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.505
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.505
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.505
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.504
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.503
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.501
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.501
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.500
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
31 |
0.496
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.496
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.495
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.495
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.492
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.492
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.491
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.489
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.485
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
14 |
0.474
|
|
|
|
muscle filament sliding
|
GO:0030049 |
1 |
0.472
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.471
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.466
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.466
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.459
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.457
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.456
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.452
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.450
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.446
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.446
|
|
|
|
regulation of cardiac muscle cell action potential
|
GO:0098901 |
1 |
0.446
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.439
|
|
|
|
positive regulation of blood circulation
|
GO:1903524 |
22 |
0.436
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.436
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.434
|
|
|
|
regulation of skeletal muscle contraction
|
GO:0014819 |
3 |
0.425
|
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.421
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.416
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.415
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.411
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.411
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.409
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.409
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.407
|
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.405
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.402
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.398
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.397
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.397
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.394
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.393
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.393
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.392
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.391
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.388
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.387
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.386
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.384
|
|
|
|
striated muscle adaptation
|
GO:0014888 |
26 |
0.378
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
26 |
0.378
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.375
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation
|
GO:0003257 |
3 |
0.371
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.371
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.371
|
|
|
|
ventricular septum morphogenesis
|
GO:0060412 |
27 |
0.369
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.368
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.366
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.363
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
15 |
0.362
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.359
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.358
|
|
|
|
positive regulation of ion transmembrane transporter activity
|
GO:0032414 |
15 |
0.357
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.356
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.355
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.355
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.352
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.350
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.349
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.349
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.345
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.345
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.344
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.336
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.329
|
|
|
|
cardiac pacemaker cell fate commitment
|
GO:0060927 |
1 |
0.328
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.316
|
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.316
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.315
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.314
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.313
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.312
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.312
|
|
|
|
sinoatrial node cell differentiation
|
GO:0060921 |
3 |
0.304
|
|
|
|
positive regulation of atpase activity
|
GO:0032781 |
3 |
0.301
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.299
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in heart development
|
GO:1901228 |
4 |
0.298
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.298
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.298
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.297
|
|
|
|
positive regulation of cardiac muscle cell proliferation
|
GO:0060045 |
15 |
0.296
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.295
|
|
|
|
coronary vasculature development
|
GO:0060976 |
12 |
0.294
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.292
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.290
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.285
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.282
|
|
|
|
tricuspid valve development
|
GO:0003175 |
3 |
0.281
|
|
|
|
atrioventricular node cell fate commitment
|
GO:0060929 |
1 |
0.280
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.276
|
|
|
|
actin myosin filament sliding
|
GO:0033275 |
1 |
0.274
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
8 |
0.274
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.271
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.270
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.268
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.267
|
|
|
|
positive regulation of ion transmembrane transport
|
GO:0034767 |
24 |
0.267
|
|
|
|
positive regulation of heart rate
|
GO:0010460 |
10 |
0.267
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.266
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.265
|
|
|
|
membrane depolarization during sa node cell action potential
|
GO:0086046 |
2 |
0.265
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.264
|
|
|
|
regulation of atpase activity
|
GO:0043462 |
9 |
0.264
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.263
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.262
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.261
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.257
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.255
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.253
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.252
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.251
|
|
|
|
response to muscle inactivity
|
GO:0014870 |
4 |
0.251
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.250
|
|
|
|
regulation of adrenergic receptor signaling pathway
|
GO:0071877 |
4 |
0.250
|
|
|
|
intrinsic apoptotic signaling pathway in response to osmotic stress
|
GO:0008627 |
2 |
0.245
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.245
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.241
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.241
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.241
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.239
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.236
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.236
|
|
|
|
cell cell signaling involved in cardiac conduction
|
GO:0086019 |
6 |
0.233
|
|
|
|
regulation of calcium ion transmembrane transport
|
GO:1903169 |
20 |
0.233
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.232
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.232
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.231
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.231
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.229
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.229
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.229
|
|
|
|
regulation of actin filament based movement
|
GO:1903115 |
12 |
0.229
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.225
|
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.223
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.222
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.221
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.219
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.219
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.216
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.216
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.216
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.215
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.215
|
|
|
|
g protein coupled receptor signaling pathway involved in heart process
|
GO:0086103 |
4 |
0.214
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.213
|
|
|
|
cardiac atrium development
|
GO:0003230 |
24 |
0.211
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.211
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.210
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.210
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.208
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.206
|
|
|
|
negative regulation of cardiac muscle tissue development
|
GO:0055026 |
8 |
0.205
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.203
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.202
|
|
|
|
sa node cell to atrial cardiac muscle cell communication
|
GO:0086070 |
5 |
0.201
|
|
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.200
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.198
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.197
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.197
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.197
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.196
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.196
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.195
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.193
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.193
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.193
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.192
|
|
|
|
alpha amino acid catabolic process
|
GO:1901606 |
18 |
0.190
|
|
|
|
positive regulation of ryanodine sensitive calcium release channel activity
|
GO:0060316 |
1 |
0.190
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.186
|
|
|
|
heart valve development
|
GO:0003170 |
23 |
0.180
|
|
|
|
regulation of skeletal muscle fiber differentiation
|
GO:1902809 |
3 |
0.178
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.176
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.176
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.176
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.175
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.174
|
|
|
|
sinoatrial node cell development
|
GO:0060931 |
3 |
0.172
|
|
|
|
regulation of heart rate by cardiac conduction
|
GO:0086091 |
6 |
0.170
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.169
|
|
|
|
neural fold elevation formation
|
GO:0021502 |
1 |
0.169
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.168
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.167
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.167
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.167
|
|
|
|
his purkinje system development
|
GO:0003164 |
4 |
0.166
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
6 |
0.165
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.164
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.164
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.164
|
|
|
|
positive regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060261 |
5 |
0.164
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.163
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.162
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.161
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.161
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.161
|
|
|
|
regulation of oxidative phosphorylation uncoupler activity
|
GO:2000275 |
3 |
0.160
|
|
|
|
positive regulation of cardiac muscle tissue development
|
GO:0055025 |
19 |
0.159
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.159
|
|
|
|
positive regulation of semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:2000764 |
1 |
0.159
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.157
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.157
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.157
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
15 |
0.157
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.156
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.155
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.155
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.155
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.154
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.153
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.153
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.152
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.151
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.150
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.150
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.150
|
|
|
|
membrane repolarization
|
GO:0086009 |
7 |
0.149
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.149
|
|
|
|
regulation of skeletal muscle fiber development
|
GO:0048742 |
36 |
0.148
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.148
|
|
|
|
hemangioblast cell differentiation
|
GO:0060217 |
1 |
0.148
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.148
|
|
|
|
globus pallidus development
|
GO:0021759 |
2 |
0.147
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.146
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.145
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.144
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.144
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.144
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.144
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.141
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.141
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.141
|
|
|
|
atrial septum primum morphogenesis
|
GO:0003289 |
3 |
0.139
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.138
|
|
|
|
positive regulation of vascular endothelial growth factor receptor signaling pathway
|
GO:0030949 |
5 |
0.138
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.137
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.137
|
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
12 |
0.137
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.136
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.136
|
|
|
|
specification of organ identity
|
GO:0010092 |
30 |
0.134
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.134
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.133
|
|
|
|
response to activity
|
GO:0014823 |
13 |
0.132
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.132
|
|
|
|
endocardial cushion development
|
GO:0003197 |
26 |
0.131
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.131
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.131
|
|
|
|
ventricular cardiac muscle cell differentiation
|
GO:0055012 |
17 |
0.130
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.130
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.130
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.130
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.129
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.128
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.128
|
|
|
|
tongue development
|
GO:0043586 |
18 |
0.128
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
27 |
0.128
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.127
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
13 |
0.127
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.127
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
2 |
0.127
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.126
|
|
|
|
positive regulation of fat cell proliferation
|
GO:0070346 |
1 |
0.126
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.125
|
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.125
|
|
|
|
megakaryocyte development
|
GO:0035855 |
15 |
0.124
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
13 |
0.124
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.124
|
|
|
|
response to stimulus involved in regulation of muscle adaptation
|
GO:0014874 |
6 |
0.123
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.123
|
|
|
|
striated muscle hypertrophy
|
GO:0014897 |
24 |
0.121
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.121
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.121
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.120
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.120
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
12 |
0.120
|
|
|
|
regulation of cardiac chamber formation
|
GO:1901210 |
1 |
0.118
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.118
|
|
|
|
response to denervation involved in regulation of muscle adaptation
|
GO:0014894 |
4 |
0.118
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
57 |
0.118
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.118
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.117
|
|
|
|
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000802 |
1 |
0.117
|
|
|
|
pancreatic a cell fate commitment
|
GO:0003326 |
2 |
0.117
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.117
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.117
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.116
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.116
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.116
|
|
|
|
regulation of vasodilation
|
GO:0042312 |
5 |
0.116
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.116
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.115
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.115
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.115
|
|
|
|
adrenergic receptor signaling pathway
|
GO:0071875 |
13 |
0.115
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.115
|
|